Pages that link to "Q48779182"
Jump to navigation
Jump to search
The following pages link to Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial (Q48779182):
Displaying 50 items.
- Gabapentin and postoperative pain: a qualitative and quantitative systematic review, with focus on procedure (Q21261955) (← links)
- Gabapentin for chronic neuropathic pain and fibromyalgia in adults (Q24194998) (← links)
- Gabapentin for chronic neuropathic pain and fibromyalgia in adults (Q24235709) (← links)
- Gabapentin for acute and chronic pain (Q24235992) (← links)
- Anticonvulsant drugs for acute and chronic pain (Q24241100) (← links)
- Opioids for neuropathic pain (Q24245218) (← links)
- Gabapentin for acute and chronic pain (Q24246411) (← links)
- Anticonvulsant drugs for acute and chronic pain (Q24246524) (← links)
- (Q24632313) (← links)
- Pharmacological management of chronic neuropathic pain - consensus statement and guidelines from the Canadian Pain Society (Q24657295) (← links)
- The provocative lumbar facet joint (Q24657809) (← links)
- Randomised controlled trial of gabapentin in Complex Regional Pain Syndrome type 1 [ISRCTN84121379] (Q24802765) (← links)
- Reward deficiency and anti-reward in pain chronification (Q26744416) (← links)
- Implementation of a publication strategy in the context of reporting biases. A case study based on new documents from Neurontin® litigation (Q27498844) (← links)
- Small-fiber neuropathy (Q28220711) (← links)
- Gabapentin inhibits high-threshold calcium channel currents in cultured rat dorsal root ganglion neurones (Q28344906) (← links)
- Block by gabapentin of the facilitation of glutamate release from rat trigeminal nucleus following activation of protein kinase C or adenylyl cyclase (Q28356452) (← links)
- Differences in reporting of analyses in internal company documents versus published trial reports: comparisons in industry-sponsored trials in off-label uses of gabapentin (Q28485343) (← links)
- The effectiveness of anticonvulsants in psychiatric disorders (Q28744504) (← links)
- Central Mechanisms Mediating Thrombospondin-4-induced Pain States (Q30276893) (← links)
- Guidelines in the management of diabetic nerve pain: clinical utility of pregabalin (Q30537158) (← links)
- Antidepressants and anticonvulsants for diabetic neuropathy and postherpetic neuralgia: a quantitative systematic review (Q30640178) (← links)
- Neuropathic pain and diabetes (Q30768015) (← links)
- Anticonvulsant drugs for acute and chronic pain. (Q30887356) (← links)
- Gabapentin reverses mechanical allodynia induced by sciatic nerve ischemia and formalin-induced nociception in mice. (Q30974413) (← links)
- Critical review of oral drug treatments for diabetic neuropathic pain-clinical outcomes based on efficacy and safety data from placebo-controlled and direct comparative studies (Q30988464) (← links)
- Maintenance of the long-term effectiveness of tramadol in treatment of the pain of diabetic neuropathy. (Q31431825) (← links)
- Gabapentin in phantom limb pain management in children and young adults: report of seven cases (Q32062830) (← links)
- When is spinal pain "neuropathic"? (Q33200878) (← links)
- The numbers needed to treat for neurological disorders (Q33231470) (← links)
- Treatment of Diabetic Sensory Polyneuropathy (Q33393882) (← links)
- Meta-analysis of duloxetine vs. pregabalin and gabapentin in the treatment of diabetic peripheral neuropathic pain (Q33408025) (← links)
- Diabetic neuropathy: mechanisms to management (Q33554384) (← links)
- The management of diabetic neuropathy in CKD. (Q33554396) (← links)
- Treating Diabetic Neuropathy: Present Strategies and Emerging Solutions (Q33583006) (← links)
- Painful diabetic neuropathy: advantage of novel drugs over old drugs? (Q33610824) (← links)
- Management of chronic pain (Q33652879) (← links)
- Vulvodynia: New Concepts and Review of the Literature (Q33706758) (← links)
- Quality of life and diabetes (Q33707382) (← links)
- Diabetic neuropathy: pathogenesis and therapy (Q33731683) (← links)
- Tricyclic antidepressant use in diabetic neuropathy (Q33735405) (← links)
- Improving the translation of analgesic drugs to the clinic: animal models of neuropathic pain (Q33746832) (← links)
- Nonepileptic uses of gabapentin (Q33756743) (← links)
- Recent advances: palliative care (Q33801768) (← links)
- Pain after spinal cord injury. (Q33841275) (← links)
- Static magnetic field therapy for symptomatic diabetic neuropathy: a randomized, double-blind, placebo-controlled trial (Q33846024) (← links)
- Gabapentin enacarbil - clinical efficacy in restless legs syndrome (Q33868110) (← links)
- Evidence-based guideline: treatment of painful diabetic neuropathy--report of the American Association of Neuromuscular and Electrodiagnostic Medicine, the American Academy of Neurology, and the American Academy of Physical Medicine & Rehabilitation (Q33870062) (← links)
- Diabetic neuropathy part 1: overview and symmetric phenotypes (Q33878023) (← links)
- Characteristics of neuropathic pain in patients with spinal cord injury (Q33882897) (← links)